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THE LANCET
Increasing incidence of Barrett’s 
oesophagus: education, 
enthusiasm, or epidemiology?
Andrzej T Prach, Thomas A MacDonald, David A Hopwood, 
David A Johnston
For unknown reasons* the incidence of oesophageal 
adenocarcinoma is rising rapidly in the U K 1 and the USA.2 
In particular in Scotland, the incidence of oesophageal 
adenocarcinoma has risen from 3-0 per 100 000 in 1976 
(age-standardised rate) to 4-6 per 100 000 in 1989.3 
Barrett's oesophagus is a premalignant metaplastic change 
in the lining of the distal oesophagus and is the only 
recognised risk factor for the development of oesophageal 
adenocarcinoma conferring a 30-125 times increased risk. 
It might be suspected that this increase of oesophageal 
adenocarcinoma is mirrored by a similar rise in the 
incidence of Barrett's oesophagus, however, currently there 
are no data to substantiate this. We have studied the 
incidence of endoscopically diagnosed Barrett’s oesophagus 
in Tayside to determine whether there is an increasing 
incidence of Barrett’s oesophagus in our population.
The incidence of endoscopically diagnosed Barrett’s 
oesophagus was determined by searching the endoscopy 
database between the years 1980 and 1993. This 
represented 53 433 upper GI endoscopies performed in our 
population of 384 000 over the 13-year period. Barrett's 
oesophagus was defined as either a positive diagnosis of 
Barrett’s determined by the endoscopist, or if the 
squamocolumnar junction was equal to, or greater than, 3 
cm above the oesophago-gastric junction. With these 
criteria 961 new cases of Barrett’s oesophagus were 
identified, representing 18 new cases per 100 000 per year 
(18 cases per 1000 endoscopies). The incidence was, 
however, not constant throughout the study period but 
showed a substantial rise from 1/100 000 per year 
(1*4/1000 endoscopies) in 1980-1981 to 48/100 000 per 
year (42*7/1000 endoscopies) in 1992-93 (see figure). 
When only cases with histological confirmation were 
considered, the incidence from 1992-93 was 18/100 000 
per year (16*5/1000 endoscopies). This latter figure 
probably underestimates the incidence of Barrett’s 
oesophagus due to the failure of some endoscopists to 
confirm the endoscopic finding of Barrett’s oesophagus 
histologically.
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Our data show a substantial rise in the incidence of 
Barrett’s oesophagus in the Tayside population. The 
reason for this changing incidence is unknown. The initial 
low incidence may be partly explained by a failure to 
recognise Barrett’s oesophagus endoscopically. With 
subsequent education on the endoscopic features of 
Barrett’s there may have been a resulting increase in 
endoscopic diagnosis. Enthusiasm towards making the 
endoscopic diagnosis of Barrett's, due to local interest in 
the condition, may have also contributed to the rising 
incidence. Changes in the GP endoscopic referral pattern, 
resulting in increased endoscopy of patients with symptoms 
of gastro-oesophageal reflux disease, a condition known to 
be related to Barrett’s oesophagus“1 may be another factor, 
However, we believe that there is a true increase in 
incidence in this condition, the cause of which is unknown. 
Irrespective of the cause, this increasing incidence has 
implications for endoscopic workload, particularly if 
surveillance for premalignant change in these patients is to 
be undertaken.5 In addition, it is of concern if it is a 
harbinger of a further increase in the incidence of 
oesophageal adenocarcinoma.
1 Reed PI. Changing pattern of oesophageal cancer. Lancet 1991; 338: 
178.
2 Hesketh PJ, Clapp RW , Doos W G , Spechler SJ, T h e  increasing 
frequency o f  adenocarcinoma o f  the esophagus. Cancer 1989; 64: 
526-30.
3 McKinney PA, Sharp L, Macfarlane GJ, M uir  CS, Oesophageal and 
gastric cancer in Scotland 1960-90, B r J  Cancer 1995; 71: 4.11-15.
4 Winters C 3 SpurlingTJ, Cliobanian SL et al. Barrett’s esophagus; a 
prevalent, occult complication o f  gastro-eosophageal reflux disease. 
Gastroenterology 1987; 92: 118-24.
5 Clark GW B} Ireland AP, DeM eester TR, Dysplasia in Barrett’s 
esophagus: diagnosis, surveillance and treatment. Dig Dis 1996; 14: 
213-27.
Departments of Digestive Diseases (A T Prach), Clinical 
Pharmacology, and Pathology, Ninewells Hospital and Medical School, 
Dundee DD1 9SY, UK
Fixation of urinary sediment
B E  van der Snoek, R A P  Koene
In patients with haematuria, the presence of dysmorphic 
erythrocytes and erythrocyte casts in the urine is a sign of a 
glomerular source of the bleeding.1 For a reliable 
interpretation of the urinary sediment, a freshly voided 
urine sample is required to avoid changes of cellular 
morphology and disappearance of cells and casts. Several 
fixation methods have been proposed, but none has gained 
wide acceptance.2'3 We found that using CellFIX, a 
formaldehyde-based fixative, it was possible to preserve the 
sediment. We compared sediments from freshly voided 
urine with sediments fixed from the same sample.
Based on the results of a previous study of fresh urinary 
sediments from 107 patients with known nephrological or 
urological causes of haematuria, we chose a value of 40% 
dysmorphic erythrocytes as the cut-off point for 
differentiating between glomerular and non-glomerular 
haematuria. By including the presence of erythrocyte casts 
as an additional criterion in that study, the sensitivity for a 
diagnosis of glomerular haematuria was 88T% and the 
specificity 100%.4 Urinary sediments were prepared by 
centrifuging 10 mL of urine for 5 min at 1500 rpm. The 
supernatant was decanted until less than 0*5 mL remained. 
One sample was examined by an experienced nephrologist 
within 3 h after voiding. Four drops of a second sample 
(about 0-2 mL) were put into a 2 mL plastic vial 
containing 0*2 mL of CellFIX (Becton Dickinson). The
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second sample was stored at room temperature and 
examined after 7-10 days by the same observer, together 
with two sediments from other patients with haematuria to 
avoid recognition of the previously examined fresh sample. 
The percentage of dysmorphic erythrocytes was assessed by 
scoring 100 cells with a light microscope (X400) the 
preparation was then screened at low magnification (X 100) 
for erythrocyte casts.
46 patients who had been referred to the urology 
department with isolated haematuria were studied. There 
was a significant correlation between the percentage of 
dysmorphic erythrocytes in the fresh and fixed samples 
(r=0*873 p<0-0001). The mean difference (SD) of the 
percentual scores of dysmorphic erythrocytes was +2-9 
(10-5)%, not significantly different from zero. Of the 23 
sediments scored as glomerular in the fresh sample only 
three were scored differently in the fixed sample (2 non- 
glomerular, 1 equivocal). None of the 20 non-glomerular 
diagnoses was scored differently. Three sediments were 
scored as equivocal/repeat in both samples.
Fixation of the urinary sediment with CellFIX does not 
lead to deformation of erythrocytes or to disappearance of 
casts after storage for up to 10 days at room temperature. 
The small vials can easily be mailed.
Research funded by the Netherlands Organisation for Scientific Research
(NWO).
1 Schramek P, Schuster FX, Georgopoulos M s et al. Value of urinary 
erythrocyte morphology in assessment o f  symptomless 
microhaematuria. Lancet 1989; ii: 1316-19.
2 Thai SMj DeBellis CC, Iverson SA, et al. Comparison of dysmorphic 
erythrocytes with other urinary sediment parameters of urinary 
bleeding. Am  J  Clin Pathol 1986; 86: 784-87.
3 Roth S, Renner E y Rathert P. Microscopic hematuria: advances in 
identification of glomerular dysmorphic erythrocytes. J  Urol 1991; 
146: 680-84.
4 Van der Snoek BE, Hoitsma AJ, van Weel C, et al. Dysmorfe 
erytrocyten in het urinesediment bij het onderscheiden van 
urologische en nefrologische oorzaken van hématurie. Ned Tijdschr 
Gcneeskd 1994; 138: 721-26.
Department of Nephrology, ( R A P  Koene) and Department of General 
Practice and Social Medicine, University Hospital Nijmegen,
PO Box 9101, 6500 HB Nijmegen, Netherlands
Endotracheal tube caecostomy
Ken Harries, Ahmed A Shandail, Brian M Stephenson
Although the use of a caecostomy seems to be declining, it 
remains a valuable option. We describe a new approach for 
the creation and subsequent closure of a temporary 
caecostomy, A purse-string is placed in the caecum and the 
bowel is decompressed. A 9 or 10 mm endotracheal tube 
(Portex Ltd) is inserted and the balloon inflated with 10-20 
mL of air. The endotracheal tube and its balloon port are 
passed through the anterior abdominal wall, secured to the 
skinj and connected to a urine bag. The caecal wall is 
then sutured to the parietal peritoneum at a convenient 
position. On removal of the tube^ the external opening
Flange of the stoma appliance fitted over the table-tennis ball
of the fistula is plugged with a table-tennis ball. A stoma 
appliance is comfortably worn over this (figure) until the 
effluent dries up.
We treated seven patients over three years. All caecostomy 
fistula have healed witiiout complications and were dry 
within 2 weeks of removal of the tube. At a median follow- 
up of 10 months there has been no recurrent fistulation to 
the anterior abdominal wall
The usual approach in the formation of a caecostomy is to 
use a Foley catheter as the method of decompression. 
However, even the larger diameter catheters are prone to 
blockage^ may be difficult to irrigate  ^ and can be complicated 
by leakage and/or subcutaneous collections.1 An endotracheal 
tube, with its wider and rigid nature, avoids these problems. 
Our stoma care nurses also suggest that skin irritation is 
minimised. On removal of the endotracheal tube, the contour 
of a table-tennis ball fits snugly over the caecostomy fistula 
and acts as a valve allowing the escape of gas but hindering 
faecal loss. To date the fistulas have all closed quickly as 
compared with when Foley catheters are used where closure 
may take 6 or more weeks.1 When inoperable large bowel 
obstruction is encountered and the patient is not expected to 
survive more than a few days we feel that an endotracheal- 
tube caecostomy allows a more comfortable and dignified 
outcome than decompression with a stoma.
1 Benacci JC, Wolff BG, Cecostomy. Therapeutic indications and 
results. Dis Colon Rectum 1995; 38: 530-34.
Department of Surgery, Royal Gwent Hospital, Newport, Gwent 
NP9 2UB, UK (B M Stephenson)
ACP0=Acute colonic pseudo-obstruction; LBOHarge bowel obstruction; *long standing ulcerative colitis.
Details of patients undergoing endotracheal tube caecostomy
Age/Sex Indication 
for caecostomy
Coexistent disease Ultimate healing at 
caecostomy site
Outcome/follow up
70/F Caecal volvulus Atrial fibrillation Yes 2 years
88/F ACP0 Renal failure, fractured hips N/A Died 4 days later
58/F Sfgmoid volvulus & 1° anastomosis None Yes 6 months
76/M ACPO Myocardial infarction Yes 3 months
46/F Caecal volvulus None Yes 9 months
39/F LBÛ Metastatic breast cancer N/A Died 12 days later
57/F LBO Metastatic colorectal cancer* N/A Died 9 days later
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